Director · ALTERITY THERAPEUTICS LTD · Ordinary shares
Side
BUY
Value
$24K
Shares
47.6K
Price
$0.5
Executed
Aug 31, 2026
Disclosed
Sep 8, 2026
Disclosure timeline8 days from execution to publication · legal deadline 2 business days
Aug 31 executedSep 8, 2026 disclosed
ATHE · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 6 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+5 / 15
1 other actor traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Marks Peter Ashley filed this Form 4 reporting a open-market purchase of ATHE on Aug 31, 2026. It became public on Sep 8, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Marks Peter Ashleycik:0002127888
Issuer
ALTERITY THERAPEUTICS LTDcik:0001131343
Revision history · 0
No field has changed since this record was first ingested.
ATHEALTERITY THERAPEUTICS LTD